Metallomics Reviews

HERFD-XAS in Metallomics: Resolving Biological Metals

November 14, 2025

Clinical Overview

This perspective reviews high energy resolution fluorescence detected X-ray absorption spectroscopy (HERFD-XAS) as an emerging tool to resolve metal and metalloid speciation in intact biological matrices, from microbial metalloenzymes to mammalian tissues and metal-chelating drugs. The authors show that, compared with conventional XAS, HERFD-XAS can sharpen near-edge features (for example, Se Kα₁ full-width at half maximum improved from 3.79 to 1.98 eV) and reliably detect dilute species such as Se at ~400–500 ppb in cartilage or Hg at ~0.5 ppm in hair. These gains enable clinically relevant discrimination of exposure routes, redox states, and ligand environments central to microbial and host metal homeostasis.

What was reviewed and who was studied

The article is a technical and biological review of HERFD-XAS across metals (Mn, Fe, Co, Ni, Cu, Zn, Mo, W, Se, Hg, Ti, lanthanides, rare earths, and Pt/Au in drugs) and matrices including metalloproteins (rubredoxin, nitrogenase, photosystem II, Fe–S clusters, ACE2), microbial and plant systems, and mammalian tissues (hair, brain, cartilage, rodent organs) and drug solutions. It synthesizes beamline physics, analyzer design, and case studies that link metal speciation to enzymatic function, toxic exposure, and chelation therapeutics.

Major Findings

DomainKey findings
Spectroscopy fundamentalsHERFD-XAS uses crystal analyzers to select specific fluorescence lines, reducing 1s core-hole lifetime broadening so that spectra become dominated by the longer-lived secondary core-hole, with more Gaussian, sharper features than conventional XAS.
Resolution and sensitivityFor Se, Kα₁ HERFD-XAS roughly halves peak widths and markedly improves signal-to-noise, enabling speciation in fish muscle (~5 μM Se) and bovine cartilage (~400–500 ppb Se); for Hg, Lα₁ HERFD-XAS discriminates multiple organomercury and inorganic species at sub-ppm levels in hair and brain.
Microbial metalloclustersHigh-resolution XAS and HERFD-XAS refine models of the Mn₄Ca cluster in photosystem II and the FeMo-cofactor in nitrogenase, clarifying metal–metal distances, oxidation states (e.g. Mo oxidation in FeMoco), and local electronic structure when combined with valence-to-core XES and specialized methods such as SpReAD.
Selective Se probesSe substitution at defined bridging positions in FeMoco, probed by Se Kα₁ HERFD-XAS, differentiates electronically distinct Fe–Se sites and, with EPR and DFT, supports a partially localized Fe oxidation pattern relevant to catalytic intermediates.
Mammalian toxicologyHg Lα₁ HERFD-XAS in human hair and brain distinguishes MeHg–thiolate, EtHg, inorganic Hg(SR)₂, and HgSe nanophases, correlating speciation with chronic dietary versus acute poisoning exposures and revealing divergent molecular fates in the CNS.
Therapeutic chelatorsCu Kα₁ HERFD-XAS of 8-hydroxyquinoline derivatives (e.g. clioquinol, PBT2) reveals square-planar versus more complex bis-ligand geometries and LMCT shake-down transitions, linking coordination geometry and ligand substitution patterns to potential brain penetration and ionophoric behavior.

Implications for Microbial Metallomics

HERFD-XAS reframes the metallome as a set of element- and site-specific electronic states that can now be resolved in situ in complex microbial and host environments, rather than as bulk metal pools.

ConceptImplication
Se Kα₁ HERFD-XAS in dilute tissues (fish muscle, cartilage, rodent blood)Enables direct speciation of selenite, seleno-amino acids, and thioselenides at physiological concentrations, supporting mechanistic links between Se metabolism, redox buffering, and tissue health or degeneration.
Hg Lα₁ HERFD-XAS in hair and brainDistinguishes MeHg[SR+N], EtHg[SR–N], Hg(SR)₂ and nano-HgSe, allowing reconstruction of exposure route and transformation pathways that may interact with microbial methylation/demethylation cycles and gut–brain metal trafficking.
Se-substituted FeMoco probed by HERFD-XASProvides a selective handle on individual Fe sites without interference from P-clusters or protein sulfur, enabling site-specific redox and protonation models of microbial nitrogen fixation relevant to synthetic catalysts and engineered diazotrophs.
Ligand K-edge HERFD-XAS for Fe–S cubanesQuantifies S 3p–Fe 3d covalency across [4Fe–4S]⁰–⁴⁺, sharpening understanding of electron distribution and valence isomerism in microbial redox relays and regulatory Fe–S proteins.
Zn Kα₁ HERFD-XAS at the ACE2 active siteDetects subtle Zn²⁺ coordination changes upon SARS-CoV-2 spike binding, suggesting that similar strategies could map infection- or drug-induced perturbations in microbial and host metalloenzymes in situ.
Cu Kα₁ HERFD-XAS for 8HQ drugsConnects chelator coordination geometry in solution to potential ionophore function, informing design of metal-modulating agents that could reshape microbial metal availability or host–pathogen competition for Cu and Zn.

Limitations

The authors emphasize that HERFD-XAS requires sophisticated, element-specific analyzer arrays and near-90° Bragg conditions; suboptimal crystal choices (e.g. Ge(844) for Se) yield only modest gains. Radiation damage, fluorescence self-absorption in concentrated samples, and limited ability to identify individual ligands or R-groups persist. Access is constrained to a few synchrotron beamlines, and data analysis (e.g. oxidation-state-mixed linear combination fitting) demands careful fluorescence-shift corrections and extensive model libraries.

Future perspectives

The review argues that broader implementation of optimized HERFD-XAS spectrometers, coupled with standardized low-temperature, low-dose protocols, will extend speciation analysis into ultra-dilute regimes across tissues, microbial cultures, and environmental samples. Likely next steps include: building richer HERFD-XAS libraries for biologically relevant Se, Hg, Fe–S, and drug complexes; combining HERFD-XAS with valence-to-core XES, crystallography, and imaging nano-XRF; and applying these workflows prospectively in studies of environmental exposure, osteoarticular disease, neurotoxicity, and metal-targeted therapeutics. The authors also foresee HERFD-XAS integrated into multimodal assessments of metal biology “across all kingdoms of life.”

Key takeaways for Researchers and Clinicians

This article reviews HERFD-XAS applied to microbial metalloenzymes, plant photosystems, mammalian hair, brain, cartilage, rodent organs, and metal-chelating drugs. The central metals are Se, Hg, Fe, Mo, Mn, Zn, and Cu, with speciation resolved at μM–ppb levels. The clearest outcome associations include source-specific Hg species in hair and brain for acute versus dietary exposure, Se thioselenide formation in cartilage under defined media, and Zn active-site distortion in ACE2 when engaged by SARS-CoV-2 spike. Methodologically, the key insight is that carefully chosen analyzer crystals and fluorescence lines (e.g. Se Kα₁ with Si(844); Hg Lα₁ with Si) transform noisy, broadened XAS into diagnostically useful speciation fingerprints.

Clinically, HERFD-XAS supports more precise exposure forensics, clarifies target engagement for metal-active drugs and chelators, and illuminates metal-linked pathogenesis in joint disease, neurotoxicity, and viral entry. A concise translational hook is that HERFD-XAS can deliver element- and site-specific speciation maps in intact biological matrices at clinically relevant concentrations, bridging metallomic signatures to diagnosis and intervention.

Citation

Baker AT, George GN, Harris HH. High Energy Fluorescence Detected X-ray Absorption Spectroscopy (HERFD-XAS) for Studies of Metals and Metalloids in Biology: Current Innovations and Future Perspectives. Metallomics. 2025;mfaf038. doi:10.1093/mtomcs/mfaf038